AR029189A1 - USE OF A PHOSPHODIESTERASE 4 INHIBITOR AND AN ANTI-INFLAMMATORY CORTICOESTEROID IN COMBINED FORM, SEPARATELY OR SEPARATELY SEQUENTIALLY FOR THE PREPARATION OF A MEDICINAL PRODUCT - Google Patents
USE OF A PHOSPHODIESTERASE 4 INHIBITOR AND AN ANTI-INFLAMMATORY CORTICOESTEROID IN COMBINED FORM, SEPARATELY OR SEPARATELY SEQUENTIALLY FOR THE PREPARATION OF A MEDICINAL PRODUCTInfo
- Publication number
- AR029189A1 AR029189A1 ARP000105742A ARP000105742A AR029189A1 AR 029189 A1 AR029189 A1 AR 029189A1 AR P000105742 A ARP000105742 A AR P000105742A AR P000105742 A ARP000105742 A AR P000105742A AR 029189 A1 AR029189 A1 AR 029189A1
- Authority
- AR
- Argentina
- Prior art keywords
- separately
- inhibitor
- phosphodiesterase
- preparation
- inflammatory
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Uso de un inhibidor de la PDE4 y de un corticosteroide anti-inflamatorio en forma combinada, separadamente, o separadamente y secuencialmente que es para la preparacion de un medicamento para tratar una enfermedad pulmonar en donde la administracion secuencial está proxima en el tiempo o remota en el tiempo, particularmente se administra un inhibidor de la fosfodiesterasa 4 tal como ácido cis-4-ciano-4-(3-ciclopentiloxi-4-metoxifenil)ciclohexan-1-carboxílico en combinacion con un corticoesteroide antiinflamatorio tal como fluticasona.Use of a PDE4 inhibitor and an anti-inflammatory corticosteroid in combination, separately, or separately and sequentially that is for the preparation of a medicament to treat a lung disease where sequential administration is time or remote in In particular, a phosphodiesterase 4 inhibitor such as cis-4-cyano-4- (3-cyclopentyloxy-4-methoxyphenyl) cyclohexane-1-carboxylic acid in combination with an anti-inflammatory corticosteroid such as fluticasone is administered.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16315899P | 1999-11-02 | 1999-11-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR029189A1 true AR029189A1 (en) | 2003-06-18 |
Family
ID=22588737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000105742A AR029189A1 (en) | 1999-11-02 | 2000-10-31 | USE OF A PHOSPHODIESTERASE 4 INHIBITOR AND AN ANTI-INFLAMMATORY CORTICOESTEROID IN COMBINED FORM, SEPARATELY OR SEPARATELY SEQUENTIALLY FOR THE PREPARATION OF A MEDICINAL PRODUCT |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP1225866A4 (en) |
| JP (1) | JP2003513028A (en) |
| KR (1) | KR20020057988A (en) |
| CN (1) | CN1387404A (en) |
| AP (1) | AP2002002496A0 (en) |
| AR (1) | AR029189A1 (en) |
| AU (1) | AU1357501A (en) |
| BG (1) | BG106748A (en) |
| BR (1) | BR0015270A (en) |
| CA (1) | CA2388333A1 (en) |
| CO (1) | CO5261512A1 (en) |
| CZ (1) | CZ20021512A3 (en) |
| DZ (1) | DZ3225A1 (en) |
| EA (1) | EA200200518A1 (en) |
| EC (1) | ECSP003747A (en) |
| HK (1) | HK1049107A1 (en) |
| HU (1) | HUP0203152A3 (en) |
| IL (1) | IL149367A0 (en) |
| MA (1) | MA26841A1 (en) |
| MX (1) | MXPA02004350A (en) |
| NO (1) | NO20022057L (en) |
| OA (1) | OA12076A (en) |
| PE (1) | PE20011005A1 (en) |
| PL (1) | PL355261A1 (en) |
| SK (1) | SK7592002A3 (en) |
| TR (1) | TR200201211T2 (en) |
| TW (1) | TWI242431B (en) |
| WO (1) | WO2001032127A2 (en) |
| ZA (1) | ZA200203435B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040242597A1 (en) * | 2001-09-19 | 2004-12-02 | Thomas Klein | Combination |
| JP2005515975A (en) * | 2001-10-31 | 2005-06-02 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | Type 4 phosphodiesterase inhibitors and uses thereof |
| UA82323C2 (en) * | 2002-08-09 | 2008-04-10 | Меда Фарма Гмбх & Ко. Кг | Novel combination of a glucocorticoid and pde-inhibitor for the treatment of respiratory diseases, allergic diseases, asthma and chronic obstructive pulmonary diseases |
| TW200410923A (en) * | 2002-10-17 | 2004-07-01 | Ono Pharmaceutical Co | Therapeutic agent for chronic obstructive pulmonary disease |
| US20060199789A1 (en) * | 2003-03-31 | 2006-09-07 | Kyowa Hakko Kogyo Co., Ltd. | medical composition |
| US20050026883A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
| JPWO2006041121A1 (en) * | 2004-10-13 | 2008-05-15 | 協和醗酵工業株式会社 | Treatment and / or prevention agent for chronic skin diseases |
| BRPI0617673C1 (en) * | 2005-10-19 | 2012-05-22 | Ranbaxy Lab Ltd | phosphodiesterase type iv inhibitor compositions |
| TWI589313B (en) | 2010-01-05 | 2017-07-01 | 麥可朵斯斯若波特公司 | Pharmaceutical delivery package and inhaler |
| WO2015063669A1 (en) | 2013-10-30 | 2015-05-07 | Wockhardt Limited | Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1466598A3 (en) * | 1993-06-18 | 2007-06-27 | Smithkline Beecham Corporation | PDE-IV inhibitors |
| DE4332041C2 (en) * | 1993-09-21 | 1997-12-11 | Rentschler Arzneimittel | Use of pentoxifylline in certain lung diseases |
| PE44995A1 (en) * | 1994-01-27 | 1995-12-18 | Schering Corp | MOMETASONE FUROATE FOR THE TREATMENT OF LUNG DISEASES AND RESPIRATORY TRACT |
| SE9801368D0 (en) * | 1998-04-20 | 1998-04-20 | Astra Ab | New use |
-
2000
- 2000-10-31 AR ARP000105742A patent/AR029189A1/en not_active Application Discontinuation
- 2000-10-31 EC EC2000003747A patent/ECSP003747A/en unknown
- 2000-11-01 CA CA002388333A patent/CA2388333A1/en not_active Abandoned
- 2000-11-01 TR TR2002/01211T patent/TR200201211T2/en unknown
- 2000-11-01 CZ CZ20021512A patent/CZ20021512A3/en unknown
- 2000-11-01 MX MXPA02004350A patent/MXPA02004350A/en unknown
- 2000-11-01 SK SK759-2002A patent/SK7592002A3/en unknown
- 2000-11-01 HU HU0203152A patent/HUP0203152A3/en unknown
- 2000-11-01 EA EA200200518A patent/EA200200518A1/en unknown
- 2000-11-01 IL IL14936700A patent/IL149367A0/en unknown
- 2000-11-01 OA OA1200200124A patent/OA12076A/en unknown
- 2000-11-01 AU AU13575/01A patent/AU1357501A/en not_active Abandoned
- 2000-11-01 PL PL00355261A patent/PL355261A1/en not_active Application Discontinuation
- 2000-11-01 AP APAP/P/2002/002496A patent/AP2002002496A0/en unknown
- 2000-11-01 BR BR0015270-6A patent/BR0015270A/en not_active IP Right Cessation
- 2000-11-01 DZ DZ003225A patent/DZ3225A1/en active
- 2000-11-01 KR KR1020027005609A patent/KR20020057988A/en not_active Application Discontinuation
- 2000-11-01 EP EP00975533A patent/EP1225866A4/en not_active Withdrawn
- 2000-11-01 JP JP2001534335A patent/JP2003513028A/en active Pending
- 2000-11-01 WO PCT/US2000/030113 patent/WO2001032127A2/en active Search and Examination
- 2000-11-01 CN CN00815265A patent/CN1387404A/en active Pending
- 2000-11-02 PE PE2000001168A patent/PE20011005A1/en not_active Application Discontinuation
- 2000-11-02 CO CO00083427A patent/CO5261512A1/en not_active Application Discontinuation
- 2000-11-22 TW TW089123039A patent/TWI242431B/en not_active IP Right Cessation
-
2002
- 2002-04-30 ZA ZA200203435A patent/ZA200203435B/en unknown
- 2002-04-30 NO NO20022057A patent/NO20022057L/en not_active Application Discontinuation
- 2002-05-02 MA MA26621A patent/MA26841A1/en unknown
- 2002-05-29 BG BG106748A patent/BG106748A/en unknown
- 2002-12-19 HK HK02109234.5A patent/HK1049107A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20022057L (en) | 2002-06-27 |
| OA12076A (en) | 2006-05-04 |
| NO20022057D0 (en) | 2002-04-30 |
| WO2001032127A2 (en) | 2001-05-10 |
| PL355261A1 (en) | 2004-04-05 |
| CZ20021512A3 (en) | 2003-04-16 |
| ZA200203435B (en) | 2003-06-25 |
| IL149367A0 (en) | 2002-11-10 |
| BG106748A (en) | 2003-02-28 |
| PE20011005A1 (en) | 2001-09-28 |
| ECSP003747A (en) | 2002-05-23 |
| SK7592002A3 (en) | 2002-11-06 |
| EP1225866A2 (en) | 2002-07-31 |
| AU1357501A (en) | 2001-05-14 |
| CO5261512A1 (en) | 2003-03-31 |
| CA2388333A1 (en) | 2001-05-10 |
| HUP0203152A2 (en) | 2003-01-28 |
| HUP0203152A3 (en) | 2004-06-28 |
| CN1387404A (en) | 2002-12-25 |
| MXPA02004350A (en) | 2002-11-07 |
| KR20020057988A (en) | 2002-07-12 |
| BR0015270A (en) | 2002-06-18 |
| JP2003513028A (en) | 2003-04-08 |
| TWI242431B (en) | 2005-11-01 |
| EP1225866A4 (en) | 2004-04-21 |
| EA200200518A1 (en) | 2002-10-31 |
| AP2002002496A0 (en) | 2002-06-30 |
| HK1049107A1 (en) | 2003-05-02 |
| WO2001032127A3 (en) | 2001-12-06 |
| DZ3225A1 (en) | 2001-05-10 |
| MA26841A1 (en) | 2004-12-20 |
| TR200201211T2 (en) | 2002-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60114571D1 (en) | PREPARATIONS WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE LUNG DISEASE | |
| DE69826644D1 (en) | TOPICAL PHARMACEUTICAL COMPOSITION CONTAINING A CHOLINERGIC ACTIVE SUBSTANCE OR A CALCIUM CHANNEL BLOCKER | |
| BR0005299A (en) | Compounds for the treatment of female sexual dysfunction | |
| ID29181A (en) | COMBINATION OF FORMOTEROL AND TIOTROPIUM SALT | |
| AR037255A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING OXIBUTININE | |
| YU106192A (en) | NEW COMBINATION OF BRONHODILATOR AND STEROID ANTI-INFLAMMATORY MEDICINE FOR TREATMENT OF RESPIRATORY DISORDERS | |
| BR0306513A (en) | medicine buffer | |
| AR042262A2 (en) | USE OF 8,9-DIHYDROESTRONE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF ATEROSCLEROSIS | |
| AR013614A1 (en) | NEW COMPOSITION THAT INCLUDES A COMBINATION OF STEROIDS, A KIT THAT CONTAINS IT, THE USE OF THE SAME, THE USE OF SUCH KIT OF FORMOTEROL AND DEBUDESONIDA IN THE MANUFACTURE OF A MEDICINAL PRODUCT | |
| CO5170471A1 (en) | MODIFIED RELEASE TABLETS INCLUDING AMOXYLIN AND POTASSIUM CLAVULANATE | |
| AR029189A1 (en) | USE OF A PHOSPHODIESTERASE 4 INHIBITOR AND AN ANTI-INFLAMMATORY CORTICOESTEROID IN COMBINED FORM, SEPARATELY OR SEPARATELY SEQUENTIALLY FOR THE PREPARATION OF A MEDICINAL PRODUCT | |
| BR9908617A (en) | Inorganic nitride and organic acid in combination as a topical antiviral composition. | |
| CY1110078T1 (en) | INJECTIONS WITH IODIDATED POVIDON FOR WASTE HEALING | |
| AR026197A1 (en) | USE OF DIPIRIDAMOL OR MOPIDAMOL FOR THE TREATMENT AND PREVENTION OF FIBRINE DEPENDENT MICROCIRCULATION DISORDERS | |
| ES2188995T3 (en) | USE OF AN INHIBITOR OF THE H +, K + -ATPASA IN THE TREATMENT OF NASAL POLYPS. | |
| BR0007613A (en) | Imidazo [1,5-a] -pyrido [3,2-e] -pyrazinones application as medicine | |
| PE20020793A1 (en) | PREVENTIVE AND / OR THERAPEUTIC AGENT OF INFLAMMATORY DISEASES OF THE RESPIRATORY TRACT | |
| BR0109747A (en) | Use of 5- (2-pyrazinyl) -4-methyl-1-2-dithiol-3-thione (oltipraz) as a medicine, pharmaceutical composition for the prevention and treatment of hepatic fibrosis progression, use of 5- (2- pyrazinyl) -4-methyl-1,2-dithiol-3-thione and method for the prevention and treatment of fibrosis progression and liver cirrhosis | |
| CR8584A (en) | PIPERAZINAS DERIVED FROM UREA FOR THE TREATMENT OF ENDOMETROSIS | |
| AR010432A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING RICHINOLEIC ACID AND ITS USE FOR ANTI-INFLAMMATORY AND ANALGESIC THERAPY | |
| WO2004033484A3 (en) | Use of stable glutamine derivatives to improve drug absorption | |
| PT927031E (en) | Pharmaceutical composition containing nimesulide for oral administration | |
| WO2001045727A3 (en) | Stabilized veterinary compositions comprising more than one antiviral agent | |
| AR109456A2 (en) | USE OF ET743 FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A HUMAN PATIENT AFFECTED BY CANCER THROUGH COMBINATION THERAPY | |
| WO2001001995A3 (en) | Method for treatment of asthma syndrome |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |